M V22 (Hydrochlorothiazide and valsartan 12.5 mg / 160 mg)
Pill imprint M V22 has been identified as Hydrochlorothiazide and valsartan 12.5 mg / 160 mg.
Hydrochlorothiazide/valsartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/valsartan 12.5 mg / 160 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M V22
- 12.5 mg / 160 mg
- Prescription only
- Drug Class:
- Angiotensin II inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide red
ferric oxide yellow
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0193||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide/valsartan
- Hydrochlorothiazide and valsartan
- Valsartan and hydrochlorothiazide (Advanced Reading)
- Other brands: Diovan HCT
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.